A new inhaled antibiotic for the treatment of cystic fibrosis called Cayston® is now available for patients through select specialty pharmacies, including the CF Services Pharmacy.
Site Search
Showing 1 - 10 of 18 results
News
|
Dec. 10, 2009
|
3 min read
News
|
Dec. 15, 2009
|
2 min read
News
|
Feb. 20, 2009
|
2 min read
News
|
Feb. 7, 2007
|
1 min read
News
|
March 19, 2007
|
2 min read
News
|
March 4, 2010
|
2 min read
A key focus of this year's North American Cystic Fibrosis Conference (NACFC) was the progress of the more than 30 potential new therapies moving through the CF Foundation's drug development pipeline.
News
|
Nov. 15, 2010
|
2 min read
Melanie Lawrence, an adult with cystic fibrosis, was selected to testify before a Senate Health, Education, Labor and Pensions subcommittee regarding the impact of antimicrobial resistance on patients who face heightened risk of infections, like those with CF.
News
|
July 12, 2023
|
3 min read
Diagnosing CF is a multistep process. A complete diagnostic evaluation should include a newborn screening, a sweat chloride test, a genetic or carrier test, and a clinical evaluation at a CF Foundation-accredited care center.
Close to 40,000 people in the U.S. have cystic fibrosis, a rare genetic disease. The majority of people with CF are diagnosed by age 2 thanks to newborn screening tests. If you have CF or are considering testing for it, knowing about the role of genetics in CF can help you make decisions about your health care.